arrow
G

Gerardo Petruzzi

University of Genoa
H指数:16
被引数:1,155

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Major salivary gland carcinomas: A 21-center cohort study of 892 patients with external validation of the UICC 9th edition n-classification

涎腺癌:一项包含892例患者的21中心队列研究及UICC第9版N分类的外部验证

2026-09-010
PRE
Integration of Patient-Reported Outcome Measures in Clinical Practice for Head and Neck Cancer Patients: A Cross-Sectional Survey

头颈癌患者临床实践中患者报告结局测量的整合:一项横断面调查

2026-05-090
OA
Italian multicentre study to validate the Swallowing Outcome After Laryngectomy (SOAL) questionnaire

意大利多中心研究以验证喉切除术后的吞咽结局(SOAL)问卷

2025-12-010
PRE
When Should Elective Neck Dissection Be Considered for Early-Stage Oral Cavity Tumors? Insights From a Multicenter Study of 1109 Patients and Development of a Multiparametric Predictive Model

何时应考虑对早期口腔癌肿瘤进行择期颈淋巴结清扫术?来自一项包含1109例患者的多中心研究及多参数预测模型构建的见解

2025-10-010
PRE
Role of Tumor-Infiltrating Lymphocytes and the Tumor Microenvironment in the Survival of Malignant Parotid Gland Tumors: A Two-Centre Retrospective Analysis of 107 Patients
2024-06-180
OAAI
Trans oral robotic surgery for oropharyngeal cancer: A multi institutional experience

口咽癌的跨口腔机器人手术: 多机构经验

EJSO
IF2.9
2023-09-014
OAAI
Small cell neuroendocrine carcinoma Merkel-like of major salivary glands: Presentation of a multicenter case series of this exceptional histological entity

主要唾液腺的小细胞神经内分泌癌Merkel样: 这种特殊组织学实体的多中心病例系列的介绍

2023-03-010
PRE
Antibody Persistence 6 Months Post-Vaccination with BNT162b2 among Health Care Workers

医护人员接种BNT162b2疫苗后6个月的抗体持久性

2021-10-0332
OAAI
Early Onset of SARS-COV-2 Antibodies after First Dose of BNT162b2: Correlation with Age, Gender and BMI
2021-06-2237
OAAI
Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine
2021-06-01133
OAAI